A-P Meert
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in ⓘ
-
- Lung Cancer Treatments and Mutations 8
- Lung Cancer Diagnosis and Treatment 3
- Oncology 8
- Lung Cancer Research Studies 6
- Co-authors
- Sculier Jp (10 shared papers)J.J. Lafitte (6 shared papers)Thierry Berghmans (7 shared papers)Céline Mascaux (6 shared papers)Bradley C. Martin (5 shared papers)Philippe Lothaire (3 shared papers)J‐M Verdebout (4 shared papers)P. Delmotte (2 shared papers)
- Journals
- British Journal of Cancer (5 papers)European Respiratory Journal (2 papers)Monaldi Archives for Chest Disease (1 paper)VUBIR (Vrije Universiteit Brussel) (1 paper)Oxford University Press eBooks (1 paper)
- Partner nations
- BelgiumFranceLuxembourg
In The Last Decade
A-P Meert
14 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 82
- Oncology 732
- Pulmonary and Respiratory Medicine 799
- Cancer Research 266
- Molecular Biology 548
- Hepatology 54
Countries citing papers authored by A-P Meert
This map shows the geographic impact of A-P Meert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A-P Meert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A-P Meert more than expected).
Fields of papers citing papers by A-P Meert
This network shows the impact of papers produced by A-P Meert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A-P Meert. The network helps show where A-P Meert may publish in the future.
Co-authors
The 25 scholars most cited alongside A-P Meert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 457 | |
| 2 | 2004 | 231 | |
| 3 | 2002 | 230 | |
| 4 | 2002 | 193 | |
| 5 | 2003 | 130 | |
| 6 | 2006 | 45 | |
| 7 | 2003 | 25 | |
| 8 | FIRST-LINE ERLOTINIB IN PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) CARRYING AN ACTIVATING EGFR MUTATION: A MULTICENTRE ACADEMIC PHASE II STUDY IN BELGIUM | 2011 | 2 |
| 9 | 2006 | 1 | |
| 10 | 2007 | 1 | |
| 11 | 2005 | 1 | |
| 12 | [Stage IV NSCLC. Place of chemotherapy]. | 2008 | 1 |
| 13 | [Indications and results of intensive care in patients with lung cancer]. | 2007 | 1 |
| 14 | 2022 | 1 | |
| 15 | [Management of extensive disease small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party]. | 2014 | 1 |
| 16 | 2023 | 0 | |
| 17 | 2019 | 0 |
About A-P Meert
A-P Meert is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Surgery and Molecular Biology, having authored 17 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Multiple and Secondary Primary Cancers (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Oncology (732 citations), Pulmonary and Respiratory Medicine (799 citations), Cancer Research (266 citations), Molecular Biology (548 citations) and Hepatology (54 citations). A-P Meert has collaborated with scholars based in Belgium, France and Luxembourg. Frequent co-authors include Sculier Jp, J.J. Lafitte, Thierry Berghmans, Céline Mascaux, Bradley C. Martin, Philippe Lothaire, J‐M Verdebout, P. Delmotte, M Paesmans and Annick Haller. Their work appears in journals such as British Journal of Cancer, European Respiratory Journal, Monaldi Archives for Chest Disease, VUBIR (Vrije Universiteit Brussel) and Oxford University Press eBooks.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.